Sham-Controlled Randomized Trials of Catheter-Based Renal Denervation in Patients With Hypertension
Partha Sardar, Deepak L Bhatt, Ajay J Kirtane, Kevin F Kennedy, Saurav Chatterjee, Jay Giri, Peter A Soukas, William B White, Sahil A Parikh, Herbert D Aronow, Partha Sardar, Deepak L Bhatt, Ajay J Kirtane, Kevin F Kennedy, Saurav Chatterjee, Jay Giri, Peter A Soukas, William B White, Sahil A Parikh, Herbert D Aronow
Abstract
Background: There are conflicting data regarding the relative effectiveness of renal sympathetic denervation (RSD) in patients with hypertension.
Objectives: The purpose of this study was to evaluate the blood pressure (BP) response after RSD in sham-controlled randomized trials.
Methods: Databases were searched through June 30, 2018. Randomized trials (RCTs) with ≥50 patients comparing catheter-based RSD with a sham control were included. The authors calculated summary treatment estimates as weighted mean differences (WMD) with 95% confidence intervals (CIs) using random-effects meta-analysis.
Results: The analysis included 977 patients from 6 trials. The reduction in 24-h ambulatory systolic blood pressure (ASBP) was significantly greater for patients treated with RSD than sham procedure (WMD -3.65 mm Hg, 95% CI: -5.33 to -1.98; p < 0.001). Compared with sham, RSD was also associated with a significant decrease in daytime ASBP (WMD -4.07 mm Hg, 95% CI: -6.46 to -1.68; p < 0.001), office systolic BP (WMD -5.53 mm Hg, 95% CI: -8.18 to -2.87; p < 0.001), 24-h ambulatory diastolic BP (WMD -1.71 mm Hg, 95% CI: -3.06 to -0.35; p = 0.01), daytime ambulatory diastolic BP (WMD -1.57 mm Hg, 95% CI: -2.73 to -0.42; p = 0.008), and office diastolic BP (WMD -3.37 mm Hg, 95% CI: -4.86 to -1.88; p < 0.001). Compared with first-generation trials, a significantly greater reduction in daytime ASBP was observed with RSD in second-generation trials (6.12 mm Hg vs. 2.14 mm Hg; p interaction = 0.04); however, this interaction was not significant for 24-h ASBP (4.85 mm Hg vs. 2.23 mm Hg; p interaction = 0.13).
Conclusions: RSD significantly reduced blood pressure compared with sham control. Results of this meta-analysis should inform the design of larger, pivotal trials to evaluate the long-term efficacy and safety of RSD in patients with hypertension.
Keywords: hypertension; renal denervation.
Copyright © 2019 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Source: PubMed